About Dr. Zhang
Xinyu Zhang, Ph.D., is a U.S. Patent Agent at ZYL Law Firm and a distinguished Research Scientist at Yale University, specializing in the intersection of computational biology and artificial intelligence.
Dr. Zhang's career spans both academic research and industrial application. At ZYL, he leverages his cutting-edge technical background to lead the development of specialized AI models and software for intellectual property law. His work pioneers the integration of artificial intelligence with legal practice, significantly enhancing the efficiency and precision of legal processes.
Academic & Research Achievements
As a prolific scholar, Dr. Zhang has authored over 50 high-impact academic papers, with his research being cited more than 3,000 times by peers worldwide. His outstanding work has earned him several international recognitions, including:
- Tied for 1st Place in Sub-challenge 2 & 1st Place in Sub-challenge 3, DREAM Single Cell Transcriptomics Challenge (2018)
- Fifth Place in Sub-challenge 2.2 and Travel Award, Parkinson’s Disease Digital Biomarker DREAM Challenge (2017)
- Tied for Third Place in Sub-challenge 2, Disease Module Identification DREAM Challenge (2016)
Representative Scientific Publications
-
Zhang XY, Hu Y, Vandernoot R, et al.
Computationally Inferred Cell-Type Specific Epigenome-Wide DNA Methylation Analysis Unveils Distinct Methylation Patterns among Immune Cells for HIV Infection in Three Cohorts.
Plos Pathogens, 2024 -
Zhang XY, Hu Y, Aouizerat BE, et al.
Machine learning selected smoking-associated DNA methylation signatures that predict HIV prognosis and mortality.
Clinical Epigenetics, 2018 -
Zhang XY, Hu Y, Justice AC, et al.
DNA methylation signatures of illicit drug injection and hepatitis C are associated with HIV frailty.
Nature Communications, 2017 -
Zhang XY, Justice AC, Hu Y, et al.
Epigenome-Wide Differential DNA Methylation between HIV-Infected and Uninfected Individuals.
Epigenetics, 2016